“Chimeric Antigen Receptor T-Cell Manufacturing Turnaround: Vein-to-Vein Time as a Clinical Variable” (2023) Translational Medicine & Therapeutics Journal, 2(1), pp. 1–9. doi:10.5281/zenodo.22649019.